OR10AA1P

Across TCGA pan-cancer cohorts, OR10AA1P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR10AA1P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher OR10AA1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR10AA1P expression acts as an unfavorable survival marker.

OV, KICH, and CHOL are the cancer types where OR10AA1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.361	0.550	.001	120	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	90	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	36	view →
KIRC	OS	Tertile	All	0.497	0.664	.007	24	view →
BLCA	DFS	Tertile	All	0.178	0.497	.045	18	view →
THCA	OS	Tertile	II,III,IV	0.936	0.985	.021	9	view →
KIRP	DFS	Tertile	All	0.791	0.922	.045	3	view →
ESCA	DFS	Tertile	All	0.418	0.560	.046	3	view →
STAD	OS	Tertile	III,IV	0.526	0.678	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR10AA1P–OV (DFS)

Open the OV breakdown →